Emphysema Completed Phase 4 Trials for Arformoterol (DB01274)

Also known as: Bullous emphysema (lung)(pulmonary) / Pulmonary Emphysema / Emphysema pulmonary

IndicationStatusPhase
DBCOND0019688 (Emphysema)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00424528Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD)Treatment